Regask Announces Us$10M Series A Funding Round Led By Monograph Capital To Accelerate Its Growth
Amount Raised
$10 Million
Round Type
Series A
SingaporeBiotechnologySoftwareHealth CareArtificial IntelligenceMachine LearningLife ScienceSaaSInvestors
Description
RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A funding round. The round is led by venture capital firm Monograph Capital and joined by SPRIM Global Investments and other investors. The funding will be used to further invest in the platform and bring RegASK to all companies seeking to strengthen their regulatory capabilities around the globe. The funding follows on the heels of the expansion of RegASK platform to serve new industries including biopharma and decentralized clinical trials regulation, in addition to the existing deployment in consumer health, medtech, and food industries.
Quick answer
RegASK raised $10 Million in a Series A round, dated December 15, 2022. Investors: Sprim Global Investments and Monograph Capital. RegASK is based in Singapore, Southeast Asia, Singapore.
- How much did RegASK raise?
- RegASK raised $10 Million in a Series A round on December 15, 2022.
- Who invested in RegASK?
- Sprim Global Investments and Monograph Capital are named as investors in this round.
- What does RegASK do?
- RegASK is a leading agentic AI regulatory intelligence and workflow orchestration platform that empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively..
- Where is RegASK based and how big is it?
- RegASK is based in Singapore, Southeast Asia, Singapore. Fundz records about 65 employees.
- Who are the decision-makers at RegASK?
- Fundz holds 1 contact at RegASK. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Life Science and SaaS around the same time
Companies in the same sectors as RegASK that raised within 45 days of this round, from Fundz verified event records.
- CodaMetrix raised $57M on December 16, 2022.
- In-Med Prognostics raised $2.1M (Seed) on December 12, 2022.
- Ibex Medical Analytics raised $10M (Funding Round) on November 9, 2022.
- Seek AI raised $7.5M (Funding Round) on January 11, 2023.
- Wingspan raised $24M on January 4, 2023.
- Kuona raised $6M (Funding Round) on December 16, 2022.
Who to call at RegASK, and when
A new round usually means RegASK is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RegASK raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RegASK, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RegASK. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RegASK raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRegASK raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.